Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Kessler

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Bleeding after treatment with rivaroxaban or apixabanCraig M Kessler
European Journal of Haematology|December 19, 2015
Acquired haemophilia: an overview for clinical practiceCraig M Kessler, Paul Knöbl
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Development of factor IX inhibitor in an adult with severe haemophilia B following COVID-19 vaccination: A case reportThita Chiasakul, Craig M Kessler
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 25, 2021
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpuraKaitlyn C Dykes, Craig M Kessler
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
A new strategy for uncontrollable bleeding after treatment with rivaroxaban or apixaban: Q&ACraig M Kessler, Joshua N Goldstein
Thrombosis and Haemostasis|July 3, 2009
Recent developments in topical thrombinsCraig M Kessler, Thomas L Ortel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
A new strategy for uncontrollable bleeding after treatment with rivaroxaban or apixabanCraig M Kessler, Joshua N Goldstein
Seminars in Thrombosis and Hemostasis|February 14, 2009
The pivotal role of thrombin in cancer biology and tumorigenesisKristen M Snyder, Craig M Kessler
British Journal of Haematology|December 7, 2021
Immune thrombocytopenia in the elderly: immunosenescent and clinical diversityJulia M Cunningham, Craig M Kessler
Annals of Internal Medicine|December 3, 2002
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrateRuby Anne E Deveras, Craig M Kessler
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Bleeding after treatment with rivaroxaban or apixabanCraig M Kessler
European Journal of Haematology|December 19, 2015
Acquired haemophilia: an overview for clinical practiceCraig M Kessler, Paul Knöbl
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Development of factor IX inhibitor in an adult with severe haemophilia B following COVID-19 vaccination: A case reportThita Chiasakul, Craig M Kessler
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 25, 2021
First report of COVID-19 vaccine induced flare of compensated congenital thrombotic thrombocytopenic purpuraKaitlyn C Dykes, Craig M Kessler
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
A new strategy for uncontrollable bleeding after treatment with rivaroxaban or apixaban: Q&ACraig M Kessler, Joshua N Goldstein
Thrombosis and Haemostasis|July 3, 2009
Recent developments in topical thrombinsCraig M Kessler, Thomas L Ortel
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
A new strategy for uncontrollable bleeding after treatment with rivaroxaban or apixabanCraig M Kessler, Joshua N Goldstein
Seminars in Thrombosis and Hemostasis|February 14, 2009
The pivotal role of thrombin in cancer biology and tumorigenesisKristen M Snyder, Craig M Kessler
British Journal of Haematology|December 7, 2021
Immune thrombocytopenia in the elderly: immunosenescent and clinical diversityJulia M Cunningham, Craig M Kessler
Annals of Internal Medicine|December 3, 2002
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrateRuby Anne E Deveras, Craig M Kessler
Pageof 9